From the Journals

Cognitive impairment in MS may affect fitness to drive motor vehicles


 

FROM MULTIPLE SCLEROSIS JOURNAL

Assessing fitness to drive a motor vehicle is an important part of clinical practice for multiple sclerosis, but MS and cognitive impairment alone don’t indicate that a patient will fail a formal road test. However, the results from a recent study indicate that one cognitive test may be able to predict the patients who would fail road tests though only with a high false-positive rate.

During 2015-2016, Sarah A. Morrow, MD, of Western University, London, Ont., and her coauthors recruited licensed drivers aged 18-59 who were diagnosed with MS. They had low physical disability (Expanded Disability Status Scale score of less than 4) but cognitive impairment in both processing speed and either memory or executive function. This set of requirements, along with the need for signed informed consent, yielded a smaller sample size (36) than the researchers’ goal, a possible weakness of the study, the investigators said (Mult Scler. 2017 Aug 7. doi: 10.1177/1352458517723991).

Multiple sclerosis is written on the screen of a tablet. HUNG KUO CHUN/Thinkstock
These subjects were given the Minimal Assessment of Cognitive Function in MS battery of tests and the formal road test. Eight of the 36 were deemed unfit to drive. Scores on one test – the immediate recall component of the Brief Visuospatial Memory Test–Revised (BVMTR-IR) – predicted all eight road-test failures, but another 18 participants who tested impaired on the BVMTR-IR did not fail the road test. This yielded a specificity of only 35.7%.

The researchers noted that, if a patient does not show impairment on the BVMTR-IR, then they will definitely pass the road test, but they also noted that showing impairment is much less likely to predict a failed test. Instead, impairment both on this test and on the Symbol Digit Modalities Test, which measures processing speed, should indicate the need for a formal driving assessment.

“This study further contributes to the clinician’s ability to identify [persons with MS] in whom fitness-to-drive should be addressed,” the investigators wrote.

Recommended Reading

Can Exercise Boost Cognitive Performance in Patients With MS?
MDedge Neurology
Researchers Compare Three Escalation Therapies for MS
MDedge Neurology
Updated Analysis of Ocrelizumab’s Safety
MDedge Neurology
Preliminary results promising from ublituximab phase II study for MS
MDedge Neurology
Integrative approach to MS care underused, expert says
MDedge Neurology
MS News From the AAN & CMSC Annual Meetings
MDedge Neurology
News Briefs From the 2017 CMSC Annual Meeting
MDedge Neurology
Disease-Modifying Drug Treatment Before, During, and After Pregnancy in Women With MS
MDedge Neurology
Is Chronic Migraine More Common in the MS Population?
MDedge Neurology
What Therapy-Related Risks Can Patients With MS Tolerate?
MDedge Neurology

Related Articles